Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma
Public ClinicalTrials.gov record NCT06563102. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-week, Randomized, Double-Blind, Phase 4 Study Evaluating the Effect of AIRSUPRA Compared to Albuterol Administered as Needed on Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization in Adults With Mild Asthma
Study identification
- NCT ID
- NCT06563102
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 101 participants
Conditions and interventions
Conditions
Interventions
- Albuterol/Budesonide Combination Product
- Albuterol Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 18 Years to 120 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 10, 2024
- Primary completion
- Feb 23, 2026
- Completion
- Feb 23, 2026
- Last update posted
- Feb 26, 2026
2024 – 2026
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85040 | — |
| Research Site | Tucson | Arizona | 85715 | — |
| Research Site | Lancaster | California | 93534 | — |
| Research Site | San Diego | California | 92123 | — |
| Research Site | Cape Coral | Florida | 33990 | — |
| Research Site | Lake Worth | Florida | 33462 | — |
| Research Site | Columbus | Georgia | 31904 | — |
| Research Site | Boise | Idaho | 83706 | — |
| Research Site | Plainfield | Indiana | 46168 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Riverdale | New Jersey | 07457 | — |
| Research Site | Oklahoma City | Oklahoma | 73120 | — |
| Research Site | North Charleston | South Carolina | 29420 | — |
| Research Site | El Paso | Texas | 79903 | — |
| Research Site | Houston | Texas | 77030 | — |
| Research Site | Waco | Texas | 76712 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06563102, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06563102 live on ClinicalTrials.gov.